ArticleHealth and quality of life outcomes2016
Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL).
Article in Health and quality of life outcomes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Pooled it
- Psychosocial Effects of Vitiligo: A Systematic Literature Review.American journal of clinical dermatology · 2021Pooled it
- Scoring Systems in Vitiligo-A Narrative Review.Indian dermatology online journal · 2026Article
- Exploring and Comparing the Psychosocial Impacts of Vitiligo on a Broader Scale: An International Survey via the Use of Social Media.The Australasian journal of dermatology · 2026Article
- Quality of life impairment in vitiligo: A comprehensive review of psychosocial and clinical determinants.The Journal of international medical research · 2026Review
- Health-Related Quality of Life and Psychological Burden of Patients With Vitiligo in Japan.The Journal of dermatology · 2026Article
- Psychosocial burden and quality of life impairment in adults with vitiligo: a cross-sectional assessment.PeerJ · 2026Article
- Psychological distress statistically mediates the association between vitiligo severity and health-related quality of life: a cross-sectional study from Kandahar, Afghanistan.Postepy dermatologii i alergologii · 2026Article
- Validation of the vitiligo-specific quality-of-life instrument (VitiQoL) for the Turkish language: the VitiQoL-TR study.Archives of dermatological research · 2025Article
- Article
- The Treatment of Refractory Vitiligo With Autologous Cultured Epithelium Grafting: A Real-World Retrospective Cohort Study.Stem cells translational medicine · 2024Article
- Impact of Vitiligo on Quality of Life in Patients of Skin of Color and Its Correlation With Clinical Severity Assessment Scores Utilizing Disease Specific Scores: A Cross-Sectional Study.Dermatology practical & conceptual · 2024Article
- Prevalence and burden of vitiligo in Africa, the Middle East and Latin America.Skin health and disease · 2024Review
- Article
- Real-World Treatment Patterns in Patients with Vitiligo in the United States.Dermatology and therapy · 2023Article
- Tetrahydrobiopterin as a Trigger for Vitiligo: Phototransformation during UV Irradiation.International journal of molecular sciences · 2023Article
- The First Live-Cell Based Product in The Iranian Drug List; ReColorCell®.Cell journal · 2023Article
- Article
- Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- Impact of narrow-band ultraviolet B radiation therapy on the quality of life of patients with vitiligo.Journal of Taibah University Medical Sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitiligo is a multi-factorial pigmentary skin disorder. Recently, the importance of emotional and psychological issues is proposed in incidence, progression, relapse and remission of vitiligo. There are limited studies conducted in developing countries, which assess life quality of patients with vitiligo. The aim of this study was the application and evaluation of a disease-specific quality of life index in Iranian patients, for the first time.
methodsThis cross-sectional biphasic study was conducted on 25 patients as a pilot and another 173 patients as the main study group, in Razi Hospital, Tehran, Iran, 2013-2014. Persian version of Vitiligo Quality of Life index (VitiQoL) was developed with backward-forward method. Based on the pilot study, the validity and reliability were assessed. The Vitiligo Area and Score Index (VASI), VitiQoL, and their relationship, demographic and clinical characteristic of patients were measured.
resultsThe Mean and standard deviation of the VitiQoL score was 30.5 ± 14.5 (range 0-60 in Persian version). There was a significant relationship between VASI score and VitiQoL (p = 0.015, r = 0.187). Confirmatory factor analysis revealed three important factors within VitiQoL: participation limitation, stigma, and behavior. In subscale analysis based on behavior factor, female patients had poorer quality of life (p = 0.02). Concomitant psychiatric problems, e.g. anxiety and depression, were not associated with QOL; however, they were near to being meaningful (p = 0.06, r = 0.14).
conclusionVitiQoL is a valid index in estimating life quality of vitiligo patients and has proper relation to disease severity. Focusing on patient's life quality is an important entity in the management of vitiligo patients; relevant supportive group-based consultations and therapies are also important arms when approaching vitiligo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.